In ₹ Crore except Per Share 12 Months Ending | Q2 FY24 30/09/2023 | Q3 FY24 31/12/2023 | Q4 FY24 31/03/2024 | Q1 FY25 30/06/2024 | Q2 FY25 30/09/2024 | Q3 FY25 31/12/2024 | Q4 FY25 31/03/2025 | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | |||||||||||||
| + Interest on Advances / Bills | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| + Income on Investments | 28.0 | 30.4 | 32.8 | 37.5 | 36.8 | 37.7 | 39.8 | 44.9 | 43.8 | 46.2 | 46.5 | 54.4 | |
| + Interest on RBI / Interbank | 8.5 | 8.7 | 8.3 | 7.7 | 10.9 | 11.7 | 12.7 | 15.6 | 16.3 | 16.8 | 17.6 | 17.8 | |
| + Other Interest | 0.0 | 0.0 | 0.3 | 0.2 | 0.0 | 0.0 | 0.4 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Earned | 36.5 | 39.2 | 41.4 | 45.3 | 47.8 | 49.4 | 52.8 | 61.0 | 60.1 | 63.0 | 64.1 | 72.2 | |
| Interest Expended | 18.9 | 21.6 | 23.0 | 23.9 | 25.1 | 25.7 | 26.0 | 28.4 | 27.6 | 29.4 | 28.9 | 35.3 | |
| Net Interest Income | 17.7 | 17.6 | 18.4 | 21.4 | 22.7 | 23.7 | 26.8 | 32.6 | 32.5 | 33.6 | 35.2 | 36.9 | |
| Other Income | 322.1 | 331.1 | 359.9 | 391.5 | 407.7 | 412.0 | 440.7 | 392.5 | 339.9 | 331.5 | 275.9 | 234.6 | |
| Total Income | 358.6 | 370.2 | 401.3 | 436.9 | 455.4 | 461.3 | 493.5 | 453.5 | 400.1 | 394.4 | 340.0 | 306.9 | |
| Operating | |||||||||||||
| + Employee Cost | 44.1 | 44.3 | 46.3 | 49.8 | 49.7 | 52.2 | 54.9 | 58.3 | 56.5 | 54.2 | 53.3 | 57.8 | |
| + Other Operating Expenses | 275.6 | 281.5 | 306.7 | 338.9 | 354.7 | 355.1 | 382.9 | 342.2 | 294.7 | 290.3 | 252.4 | 227.4 | |
| Operating Expenses | 319.6 | 325.8 | 353.0 | 388.7 | 404.4 | 407.2 | 437.8 | 400.5 | 351.2 | 344.5 | 305.7 | 285.3 | |
| Operating Profit (PPOP) | 20.1 | 22.8 | 25.3 | 24.3 | 25.9 | 28.5 | 29.7 | 24.6 | 21.2 | 20.6 | 5.4 | -13.7 | |
| Provisions & Contingencies | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Profit | |||||||||||||
| Pretax Income | 19.5 | 22.8 | 25.3 | 24.3 | 25.9 | 28.5 | 29.7 | 24.6 | 21.2 | 17.5 | 4.1 | -13.7 | |
| Tax Expense | 0.0 | 0.0 | 0.1 | 0.0 | 4.8 | 5.3 | 5.7 | 6.9 | 5.9 | 5.2 | -3.0 | 0.0 | |
| Net Income | 19.5 | 22.8 | 25.2 | 24.3 | 21.2 | 23.1 | 24.0 | 17.8 | 15.4 | 12.3 | 7.1 | -13.7 | |
| Net Income to Common | 19.5 | 22.8 | 25.2 | 24.3 | 21.2 | 23.1 | 24.0 | 17.8 | 15.4 | 12.3 | 7.1 | -13.7 | |
| Per Share | |||||||||||||
| Basic EPS | 2.35 | 2.74 | 3.03 | 2.92 | 2.54 | 2.78 | 2.89 | 2.13 | 1.84 | 1.47 | 0.85 | -1.65 | |
| Diluted EPS | 2.35 | 2.74 | 3.02 | 2.91 | 2.53 | 2.76 | 2.88 | 2.13 | 1.84 | 1.47 | 0.85 | -1.65 | |
| Book Value per Share | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 | — | 0.0 | 0.0 | |
| Per Share — as-filed variants | |||||||||||||
| Basic EPS before Extraordinary Items | 2.35 | 2.74 | 3.03 | 2.92 | 2.54 | 2.78 | 2.89 | 2.13 | 1.84 | 1.47 | 0.85 | -1.65 | |
| Diluted EPS before Extraordinary Items | 2.35 | 2.74 | 3.02 | 2.91 | 2.53 | 2.76 | 2.88 | 2.13 | 1.84 | 1.47 | 0.85 | -1.65 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | |||||||||||||
| Related-party Transactions — During the Period | — | — | — | — | — | — | 4.1 | — | 4.9 | — | 8.0 | — | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||||||||
| Cet1 Ratio | 0.78 | 0.76 | 0.79 | 0.76 | 0.75 | 0.61 | 0.74 | 0.67 | 0.70 | 0.67 | 0.75 | 0.73 | |
| Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.1 | -1.3 | 0.0 | |
| Expenditure Ex Provisions | 338.5 | 347.4 | 376.0 | 412.6 | 429.5 | 432.9 | 463.8 | 428.8 | 378.8 | 373.9 | 334.6 | 320.6 | |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Filed Roa | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | |
| Paid Up Equity Capital | 83.2 | 83.2 | 83.2 | 83.2 | 83.2 | 83.2 | 83.2 | 83.2 | 83.2 | 83.2 | 83.2 | 83.2 | |
| Pat Ordinary | 19.5 | 22.8 | 25.2 | 24.3 | 21.2 | 23.1 | 24.0 | 17.8 | 15.4 | 12.3 | 7.1 | -13.7 | |